ArticleJournal of controlled release : official journal of the Controlled Release Society2015

Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.

Bonnie L Hylander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.